Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Newer peritoneal dialysis solutions.

R Gokal1

  • 1Department of Renal Medicine, Manchester Royal Infirmary, Manchester, England. Khulme@renal.cmht.nwest.nhs.uk

Advances in Renal Replacement Therapy
|November 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcome of pregnancy following renal transplantation.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2004
Same author

Bacillus circulans peritonitis in a patient treated with CAPD.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2004
Same author

End-stage renal disease in Indo-Asians in the North-West of England.

QJM : monthly journal of the Association of Physicians·2003
Same author

Treatment of infections in peritoneal dialysis.

Contributions to nephrology·2003
Same author

Peritoneal dialysis as the first-choice treatment.

Contributions to nephrology·2003
Same author

Side-effects of antituberculosis drug treatment in patients with chronic renal failure.

The European respiratory journal·2002
Same journal

Needed: a catalyst for change.

Advances in renal replacement therapy·2004
Same journal

Racial and ethnic differences in the incidence and progression of focal segmental glomerulosclerosis in children.

Advances in renal replacement therapy·2004
Same journal

Incorporating ethnic and cultural food preferences in the renal diet.

Advances in renal replacement therapy·2004
Same journal

Literature review and implications for social work practice with Hispanic dialysis patients.

Advances in renal replacement therapy·2004
Same journal

Diversity and patient care in a shrinking world.

Advances in renal replacement therapy·2004
Same journal

Genetic variation in the epithelial sodium channel: a risk factor for hypertension in people of African origin.

Advances in renal replacement therapy·2004
See all related articles

Current peritoneal dialysis (PD) solutions are effective but can harm the peritoneal membrane. Newer PD solutions offer improved biocompatibility and fluid management, representing advancements in dialysis therapy.

Area of Science:

  • Nephrology
  • Biomaterials Science
  • Medical Chemistry

Background:

  • Conventional peritoneal dialysis (PD) solutions effectively manage waste, fluid, and electrolytes.
  • However, long-term use of current PD solutions is linked to peritoneal membrane damage, with glucose being a key factor.
  • This necessitates the development of more biocompatible alternatives.

Purpose of the Study:

  • To evaluate the biocompatibility and efficacy of novel peritoneal dialysis solutions.
  • To explore advancements in PD fluid composition for improved patient outcomes.
  • To address the limitations of traditional glucose-based PD solutions.

Main Methods:

  • Review of existing literature on PD solution composition and effects.
  • Analysis of clinical data on newer PD solutions including icodextrin, bicarbonate, and amino acids.

Related Experiment Videos

  • Assessment of studies investigating glucose degradation products in PD fluids.

    • Main Results:

    • Newer PD solutions demonstrate enhanced biocompatibility compared to conventional ones.
    • Icodextrin and bicarbonate-based solutions show promise in fluid management and reduced peritoneal damage.
    • Reduced glucose degradation products contribute to improved membrane tolerance.

    Conclusions:

    • Novel PD solutions offer significant advantages in biocompatibility and long-term peritoneal membrane health.
    • Future PD therapies will likely involve tailored combinations and additives for personalized treatment.
    • Advancements in PD solutions are crucial for improving the quality of life for dialysis patients.